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Abstract: Osteoporosis is more common in patients with COPD and in smokers. The aim of this 
study was to assess whether measures of emphysema and airway disease on computed tomography 
(CT) were associated with lower bone density or vertebral fractures in smokers with and without 
COPD. For this purpose, we included participants from the NELSON lung cancer screening 
trial. Bone density was measured as Hounsfield Units in the first lumbar vertebra, and vertebral 
fractures were assessed semiquantitatively. The 15th percentile method (Perc15) was used to 
assess emphysema, and the airway lumen perimeter (Pi10) was used for airway wall thickness. 
Expiratory/inspiratory-ratio
mean lung density
 (E/I-ratio
MLD
) was used as a measure for air trapping and 
tracheal index to assess tracheal deformity. Linear regression models and logistic regression 
models were used to assess associations between CT biomarkers, bone density, and presence of 
fractures. Exactly 1,093 male participants were eligible for analysis. Lower Perc15 and higher 
E/I-ratio
MLD
 were significantly associated with lower bone density (b=−1.27, P=0.02 and b=−0.37, 
P=0.02, respectively). Pi10 and tracheal index were not associated with bone density changes. 
CT-derived biomarkers were not associated with fracture prevalence. Bone density is lower 
with increasing extent of emphysema and small airway disease but is not associated with large 
airway disease and tracheal deformity. This may indicate the necessity to measure bone density 
early in smokers with emphysema and air trapping to prevent vertebral fractures.
Keywords: phenotyping, computed tomography, air trapping, emphysema, COPD, bone 
density
Introduction
Systemic consequences of COPD, such as cachexia, skeletal muscle wasting, and 
anemia, significantly contribute to the burden of disease.1,2 The high prevalence of 
osteoporosis in COPD patients is especially problematic because fractures can lead 
to substantial disability.3–5
Although the exact pathophysiological relationship between osteoporosis and 
COPD remains largely unknown, studies have shown similarities between emphysema 
and osteoporosis in loss of extracellular matrix and associations with inflammatory 
mediators such as tumor necrosis factor-α.6,7 Also, Ohara et al8 showed that a relation-
ship exists between emphysema and low bone mineral density (BMD) on dual X-ray 
absorptiometry. However, less is known on the relationship between bone density 
and airway disease. Computed tomography (CT) is increasingly used to identify bio-
markers to classify COPD patients, and it could be helpful in studying the association 
between morphologic abnormalities underlying COPD and osteoporosis.9 Next to 
smoking-related lung changes on CT, bone density measurements based on Hounsfield 
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unit (HU) could provide a measure for osteoporosis and are 
increasingly being investigated as a diagnostic aid.10,11 A 
recent study showed that bone density measured with CT 
could be used to identify patients with osteoporosis.12
We hypothesized that lower bone density and vertebral 
fractures could be found more often in COPD patients with 
an emphysema-dominant phenotype, compared to COPD 
patients in whom chronic bronchitis is more evident. This 
is in line with the hypothesis of an overall wasting COPD 
phenotype, although these pulmonary and skeletal changes 
might already be present before COPD is diagnosed.13 There-
fore, the purpose of this study was to assess the association 
of bone density (as a proxy for osteoporosis) and vertebral 
fractures with several CT quantification measures for lung 
abnormalities in smokers with and without COPD.
Methods
Participants
The included participants were part of the Dutch and Belgium 
Lung Cancer Screening Trial (NELSON trial).14 After gaining 
information on smoking history, which was derived from 
questionnaires sent to the general population aged between 
50 years and 75 years, participants were invited to partici-
pate in the study.15 The NELSON trial included current and 
former smokers aged between 50 years and 75 years, with a 
smoking history of at least 16.5 pack-years. Former smokers 
should not have quit more than 10 years prior to inclusion. 
Participants were excluded based on self-reported poor 
health status or if they were unable to climb two flights of 
stairs, had a recent chest CT scan, had a history of cancer, or 
a body weight of more than 140 kg. The Ministry of Health 
of the Netherlands and the institutional ethical review board 
approved the NELSON trial. The NELSON trial is registered 
at www.trialregister.nl with trial number ISRCTN63545820 
(Institutional Review Board approval number 03/040). Writ-
ten informed consent was obtained from all participants. A 
random subset of participants selected from the University 
Medical Center Utrecht underwent additional lung function 
tests and expiratory CT and were included in the present 
study.16 Because of logistical reasons, not all participants 
underwent lung function testing.
CT acquisition
All participants underwent a low-dose paired inspiratory and 
expiratory volumetric CT scan, which was acquired with 
16×0.75 mm collimation (Brilliance 16P; Philips Healthcare, 
Best, the Netherlands). Scans were made without intravenous 
contrast injection. For the inspiratory CT, participants 
weighing 80 kg or less were scanned with 120 kVp at 
30 mA, and participants weighing 80 kg were scanned with 
140 kVp at 30 mA (estimated effective dose of 1.40 mSv). 
For the expiratory CT, participants were scanned at 90 kVp 
(80 kg) or 120 kVp (80 kg) at 20 mA (estimated effec-
tive dose of 0.65 mSv). Axial images with a slice thickness 
of 1.0 mm were reconstructed at 0.7 mm increment using a 
smooth reconstruction filter (B-filter; Philips Healthcare).
CT assessment of emphysema, airway 
wall thickness, air trapping, and tracheal 
index
The quantification of emphysema and airway wall thick-
ness has been reported before.17,18 All quantifications were 
performed with CIRRUS Lung 12.03 (Cirrus, Diagnostic 
Image Analysis Group, Radboud University Medical Center, 
Nijmegen, the Netherlands; Fraunhofer MEVIS, Bremen, 
Germany). The lungs were segmented, and large airways 
were excluded. Severity of emphysema was assessed with 
the 15th percentile (Perc15) technique. This technique 
acquires the HU point below which 15% of the voxels are 
distributed.19 The closer the Perc15 is to −1,000 HU, the more 
emphysema is present.
For analysis of large airway disease, the airway lumen 
was automatically segmented as previously described.20 
Airway wall thickness was calculated by the square root of 
wall area for a theoretical airway with an internal perimeter of 
10 mm (Pi10). Airway wall borders were visually inspected 
to verify correct segmentation.21
CT air trapping was defined as the expiratory to inspira-
tory ratio of mean lung density (expiratory/inspiratory- 
ratio
mean lung density
 [E/I-ratio
MLD
]) and was used as a measure 
of small airway dysfunction.22 Tracheal index (TI) was 
measured on inspiratory scans at every slice from 2.5 cm 
above the bifurcation of the main bronchi to the top of the 
trachea.23,24 TI was defined by the ratio of coronal and sagit-
tal length of the trachea on the axial plane. Figures 1 and 2 
illustrate all CT-derived measurements.
Bone density and fracture assessment
Bone density measurements and fracture assessment have 
been reported before.25 Bone density measurements were 
performed in the first lumbar vertebra (L1). If L1 was 
fractured or not visualized, bone density was measured in 
a visible adjacent normal vertebra. A region of interest was 
placed in axial view in the upper part of the vertebra between 
the endplate and the entrance of the vessels at the anterior 
midportion, in a homogeneous area of trabecular bone 
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(Figure 3). Regions of interest were as large as possible, and 
focal heterogeneous areas were avoided. All measurements 
were taken by a research student (WJ) under the supervision 
of a chest radiologist (PJ). Vertebral fracture assessment 
was conducted in a sagittal plane. Height loss of 20% was 
considered a vertebral facture, compared to an adjacent, 
nonfractured vertebra. Fracture assessment was executed 
using semiquantitative method of Genant et al.26
Pulmonary function testing
All participants underwent prebronchodilator pulmonary 
function tests according to the European Respiratory Society/
American Thoracic Society guidelines with ZAN equipment 
(ZAN Messgeräte GmbH, Oberthulba, Germany).27 Forced 
expiratory volume in 1 second (FEV
1
) and forced vital 
capacity were measured. COPD was defined according to 
the Global Strategy for the Diagnosis, Management, and 
Prevention of COPD (Global Initiative for Chronic Obstruc-
tive Lung Disease).1
statistical analysis
Mean and standard deviation (SD) values were calculated 
for normally distributed data and median and interquartile 
range for non-normally distributed data. Univariate analyses 
were used to assess the association of bone density with 
CT-related COPD measures (Perc15, Pi10, E/I-ratio
MLD
, and 
TI) and demographic characteristics (age, body mass index 
[BMI], smoking status, pack-years, FEV
1
 % predicted, and 
COPD status [absent/present]). Biomarkers with a P-value 
of 0.20 were included in a multivariate linear regression 
model.
To compare Pi10, Perc15, E/I-ratio
MLD
, and TI between 
participants with and without a fracture, a Student’s t-test was 
performed. Logistic regression was used to study the association 
? ?
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???????????????
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Figure 1 Illustration of the lung segmentation process and calculation of emphysema, air trapping, and TI.
Notes: (A) axial inspiratory CT image. (B) axial expiratory CT image. Both (A and B) show lung segmentation (outlined green area) of the right and left lung on an axial 
slice. The trachea was segmented as well. (C) Magnified image of the trachea as shown in (A). TI is computed as follows. First, the centroid of the trachea is computed. Then, 
two orthogonal axes (0° and 90°) are drawn that cross the centroid (red lines). TI is computed as the ratio of the coronal and sagittal lines. (D) graph showing attenuation 
histograms for the inspiratory and expiratory CT. The 15th percentile (measure for emphysema) is calculated as the hU point below which 15% of the voxels are distributed. 
air trapping is calculated as the ratio of MlD on the expiratory and inspiratory images.
Abbreviations: CT, computed tomography; HU, Hounsfield Unit; MLD, mean lung density; TI, tracheal index.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f C
hr
on
ic 
O
bs
tru
ct
ive
 P
ul
m
on
ar
y 
Di
se
as
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
14
5.
5.
17
6.
8 
on
 2
6-
Ju
l-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of COPD 2016:11submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1210
Pompe et al
????????????? ?????????
???
?????
??
???? ???? ????
????
?
??
??
?
??
?
?
?
?
??
??
??
?
??
???? ????
Figure 2 Illustration of the bronchial segmentation process and the calculation of bronchial wall thickness.
Notes: (A) Bronchial tree segmentation of the right and left lung, separately and combined. (B) random selection of bronchial cross sections, showing an inner and an outer 
wall boundary (yellow and orange lines). From these boundaries, the wall area is calculated. (C) line graph in which the square root of the wall area is plotted against the 
internal perimeter. a regression line (dashed line) is drawn through the measurements, from which the square root of wall area for a theoretical bronchus with 10 mm lumen 
perimeter (ie, Pi10) was calculated (dotted lines). adapted from Mets OM, schmidt M, Buckens CF, et al. Diagnosis of chronic obstruc tive pulmonary disease in lung cancer 
screening Computed Tomogra phy scans: independent contribution of emphysema, air trapping and bronchial wall thickening. Respir Res. 2013;14:59.20
Abbreviations: Pi10, airway wall thickness at an internal perimeter of 10 mm; l, left; r, right; P, posterior; a, anterior; h, head; I, inferior.
?????
?????
??????
??????
??????
??????
Figure 3 CT-derived bone density measurements of the spine.
Notes: regions of interest (rectangular regions) were placed in the trabecular bone between the superior endplate and the middle of the corpus of vertebral body 1 (l1). 
The three axial images show vertebrae from different participants with different bone densities, viewed in bone window (C=300, W=1,600). The rectangular regions of 
interest correspond to the regions of interest placed over the vertebrae. From left to right and top to bottom, it shows gradual increase in bone density from 30 hU to 100 
and 170 hU, respectively.
Abbreviations: CT, computed tomography; HU, Hounsfield Unit.
of vertebral fractures with Perc15, Pi10, E/I-ratio
MLD
, and TI, 
while adjusting for demographic characteristics. A significance 
level of P0.05 was considered significant. Statistical Package 
for the Social Sciences Version 20 was used for all statistical 
analyses (IBM Corporation, Armonk, NY, USA).
Results
Participants
Exactly 1,140 male participants were included with a mean 
(SD) age of 62.5 (5.3) years. Forty-seven participants were 
excluded because TI or Pi10 measurements failed, resulting 
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in 1,093 participants analyzed in the current study. Approxi-
mately one-third of the participants were classified as having 
COPD (n=412; 37.7%), and 509 participants (46.6%) were 
former smokers. Further characteristics of the participants are 
shown in Table 1. Mean values of Perc15, Pi10, E/I-ratio
MLD
, 
and TI are shown in Table 2.
Bone density and CT-related COPD 
measures
The majority of bone density measurements were performed 
in L1 (n=938, 85.8%). Because of inhomogeneities and/or 
fractures in L1 or nonvisualization of L1, 140 measurements 
were performed in the 12th thoracic vertebra (12.8%), 13 in 
the eleventh thoracic vertebra (1.2%), and one in the second 
lumbar vertebra (0.1%). Overall mean (SD) bone density 
was 105.9 (33.3) HU.
Univariate results are shown in Table 3. Age, pack-years, 
smoking status, FEV
1
 % predicted, COPD status, Perc15, 
and E/I-ratio
MLD
 were included in the multivariate model. 
BMI, Pi10, and TI were not associated with bone density 
in univariate analyses. In Table S1, the results of the first 
multiple linear regression model with bone density as 
outcome are shown. In this model, pack-years, FEV
1
 % 
predicted, and COPD status did not associate independently 
with bone density. The second and final model included 
age, smoking status, Perc15, and E/I-ratio
MLD
 (Table 4). 
With every year of aging, bone density lowers by 1.75 HU 
(P0.001). Current smokers have an 8.89 HU lower bone 
density (P0.001). When Perc15 lowers by 10 HU, the 
bone density lowers by 1.27 HU (P=0.02), and when 
E/I-ratio
MLD
 increases by 1%, the bone density lowers by 
0.37 HU (P=0.02).
When comparing the effects of Perc15 and E/I-ratio
MLD
 
on bone density by standardization of the effect of one 
SD change, Perc15 resulted in a 2.42 HU lower bone density 
and E/I-ratio
MLD
 resulted in a 2.29 HU lower bone density. 
As an example, Figure 4 includes images of a participant with 
normal Perc15 and normal bone density and a participant 
with low Perc15 and low bone density.
Fracture prevalence and CT-related 
COPD measures
Of 1,093 participants, 95 had a vertebral fracture (8.7%). 
Participants with a fracture had a 1.4 HU lower Perc15 
(P=0.02). Pi10, E/I-ratio
MLD
, and TI were not significantly 
different in participants with a fracture, compared to 
those without (P=0.43, P=0.43, and P=0.24, respectively) 
(Table 2). Table 5 shows the outcomes of the logistic 
regression analysis. None of the CT-related COPD mea-
sures were associated with the presence of a fracture. Only 
bone density (P0.01) and smoking status (P=0.03) were 
associated with the presence of a fracture. For the complete 
model (Table S2).
Discussion
The purpose of this study was to assess the association 
between bone density and morphologic lung changes on 
CT in heavy smokers. Our data showed that patients with 
emphysema and air trapping have lower bone density. We 
did not find an association between airway wall thickness 
or trachea deformity and bone density. Also, the presence 
of COPD was not associated with bone density or fracture 
presence. Thus, low bone density is not disease-specific for 
COPD, but rather phenotype-specific (emphysema or small 
Table 1 Participant characteristics (n=1,093)
Characteristic Value
age (years), mean ± sD 62.5±5.3
BMI (kg/m2), mean ± sD 27.1±3.6
Pack-years (years), median  
(25th percentile–75th percentile)
40.9 (28.0–49.5)
Current smoker, n (%) 584 (53.4%)
FeV1 (% predicted), mean ± sD 95.1±17.5
COPD, n (%) 412 (37.7%)
gOlD 1, n (% of COPD positive) 264 (24.2%)
gOlD 2, n (% of COPD positive) 125 (11.4%)
gOlD 3, n (% of COPD positive) 23 (2.1%)
Bone density (hU value), mean ± sD 105.9±33.3
Prevalent fracture, n (%) 95 (8.7%)
Abbreviations: BMI, body mass index; FeV1, forced expiratory volume in 1 second; 
GOLD, Global Initiative for Chronic Obstructive Lung Disease; HU, Hounsfield 
Unit; sD, standard deviation.
Table 2 Mean values for CT-acquired measurements for the complete cohort and for participants with and without a fracture
Variable All participants  
(mean ± SD)
Participants with  
fracture (n=95)
Participants without  
fracture (n=998)
P-value
Pi10 (mm) 2.4±0.5 2.5±0.5 2.4±0.5 0.43
Perc15 (hU) −907.6±19.1 −908.9±22.0 −907.5±18.8 0.02
e/I-ratioMlD 83.7±6.2 84.8±5.6 83.6±6.2 0.43
TI 0.7±0.1 0.7±0.1 0.7±0.1 0.24
Abbreviations: CT, computed tomography; e/I-ratioMlD, expiration to inspiration ratio of mean lung density; HU, Hounsfield Unit; Perc15, emphysema score as 15th 
percentile of attenuation distribution curve on inspiratory scan; Pi10, airway wall thickness at an internal perimeter of 10 mm; sD, standard deviation; TI, tracheal index.
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airway disease), and could therefore provide relevant prog-
nostic information in a specific group of smokers.
With CT, we are able to directly measure the presence 
of airway wall thickening from large and medium airways 
(2–2.5 mm) by using Pi10 and indirectly measure the pres-
ence of air trapping (ie, small airway disease; airways 2 mm) 
by using E/I-ratio
MLD
.28 Therefore, Pi10 and E/I-ratio
MLD
 are 
thought to represent different anatomical parts of the airway 
tree. In this study, we showed that bone density was associ-
ated with emphysema and small airway disease, but airway 
wall thickening of the larger airway walls was not. The dis-
crepancy between the association of E/I-ratio
MLD
, Pi10, and 
bone density might be explained by a difference in underlying 
systemic processes in small and large airway disease.29
There are several studies that evaluated bone density 
in participants with COPD. Ohara et al8 used CT measure-
ments to evaluate 65 COPD patients with emphysema and 
showed that pulmonary emphysema was associated with 
reduced bone density. Our study confirmed these results 
in a larger study population, but we also included current 
and former smoking participants without COPD and evalu-
ated other smoking-related changes such as small airway 
Table 3 Univariate linear regression analyses for all variables 
with bone density as outcome
Variable B (SE) P-value
age (years) −1.78 (0.19) 0.001
BMI (kg/m2) 0.27 (0.28) 0.33
Pack-years −0.12 (0.06) 0.04
smoking status 5.79 (2.01) 0.004
FeV1 % predicted 0.15 (0.06) 0.008
COPD status 8.11 (2.06) 0.001
Perc15 0.19 (0.05) 0.001
Pi10 −0.19 (1.97) 0.92
e/I-ratioMlD −0.78 (0.16) 0.001
TI 8.99 (10.29) 0.38
Abbreviations: B, unstandardized coefficient; BMI, body mass index; E/I-ratioMlD, 
expiration to inspiration ratio of mean lung density; FeV1, forced expiratory volume 
in 1 second; Perc15, emphysema score as 15th percentile of attenuation distribution 
curve on inspiratory scan; Pi10, airway wall thickness at an internal perimeter of 
10 mm; se, standard error; TI, tracheal index.
Table 4 Final multiple linear regression model for associated variables and their effect on bone density
Variable Increment or comparison Change in bone density  
per unit change in variable
95% CI P-value
age (years) Plus 1 year −1.75 −2.12 to −1.38 0.001
smoking status Current versus former smoker −8.89 −12.77 to −5.01 0.001
Perc15 Decrease of 10 hU −1.27 −2.31 to −0.02 0.02
e/I-ratioMlD Increase of 1% −0.37 −0.69 to −0.05 0.02
Abbreviations: CI, confidence interval; E/I-ratioMlD, expiration to inspiration ratio of mean lung density; HU, Hounsfield Unit; Perc15, emphysema score as 15th percentile 
of attenuation distribution curve on inspiratory scan.
disease, large airway disease, and trachea deformity, next to 
emphysema. In this way, the impact of COPD and different 
characteristics of COPD on bone density could be evalu-
ated. Bon et al30 showed there was a strong and independent 
association between emphysema and low bone density as 
well, but they only used visual emphysema scores.
Rutten et al13 demonstrated that fat-free mass index, as a 
measure of muscle wasting, decreases as the level of emphy-
sema increases in participants with COPD. This relationship 
was independent of airway wall thickness. Our study comple-
mented these findings by showing an independent associa-
tion between emphysema and bone density. Moreover, we 
added E/I-ratio
MLD
 as a measure for air trapping and TI for 
trachea deformity.
When interpreting the results of the study by Rutten et al 
combined with the results of our present study, there is an indi-
cation that an emphysema phenotype does not only involve 
destruction of alveolar walls, but also systemic processes 
that result in destruction of soft tissue and bone.31 While the 
pathophysiological relationship between tissue inflammation 
and destruction in the lungs and in the whole body is not con-
firmed yet, it is hypothesized that an inflammatory response 
resulting in protease antiprotease imbalance could lead to 
tissue destruction in both lungs and the whole body.32
A vertebral fracture in COPD patients may interfere with 
these patients’ already compromised pulmonary function.5 
Therefore, early recognition of low bone density in this 
patient group is of great importance in order to prevent a 
fracture. Several factors have been reported to contribute 
to reduced bone density in COPD patients, such as BMI, 
FEV
1
, smoking, inactivity, and corticosteroid therapy.33,34 Our 
results show that smokers with emphysema and air trapping 
are more at risk for lower bone density than smokers with 
large airway disease. With this, a specific patient group could 
be examined and possibly be selected for preventive care.
Our study has limitations. First, our cohort consisted of 
only male participants with mild emphysema. However, it 
has been shown that osteoporosis affects men with severe 
COPD to a similar degree as females, which highlights the 
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correlation study available for E/I-ratio
MLD
 as a measure 
of air trapping. However, several studies have shown that 
E/I-ratio
MLD
 is the most suitable criterion for assessing small 
airway disease.21,23,39 Lastly, we only included emphysema, 
air trapping, and airway wall thickening as CT measures 
of lung disease but did not include signs of interstitial lung 
disease, which has been shown to be associated with BMD 
as well.40,41
Conclusion
This study showed that bone density is significantly lower 
in smokers with emphysema and small airway disease on 
CT. It is, however, not associated with large airway wall 
thickening or trachea deformity. These extrapulmonary 
skeletal impairments in patients with emphysema and small 
airway disease support the thought on the existence of a 
Figure 4 CT images of two participants.
Notes: lung images are shown in lung window (C=−600, W=1,600) and vertebral images in bone window (C=300, W=1,600). (A and B) show CT images of a currently 
smoking participant of age 65 years (49.5 pack-years). he does not have COPD. The images show normal lung and bone tissue on CT. Perc15 was −852 hU, and bone 
density was 150 hU. (C and D) show CT images of a 63-year-old currently smoking participant (38 pack-years). he is diagnosed with COPD gOlD stage 2. The lung image 
clearly shows signs of emphysema and Perc15 was −957 hU. Bone tissue was visually less dense when compared with image (B). Measured bone density was 39 hU.
Abbreviations: CT, computed tomography; GOLD, Global Initiative for Chronic Obstructive Lung Disease; HU, Hounsfield Unit; Perc 15, emphysema score as 15th 
percentile of attenuation distribution curve on inspiratory scan.
importance of early screening in men as well.35 Second, we 
did not measure fat-free mass or the use of corticosteroid 
drugs, while both are associated with bone density.36,37 
Although fat-free mass could be a better method to evaluate 
soft tissue loss, BMI has been shown to be correlated with 
low BMD in patients with COPD.38 Because our population 
was considered to be relatively healthy, the impact of the 
use of corticosteroids could be limited. Third, unlike emphy-
sema and airway wall thickening, there is no pathological 
Table 5 Logistic regression model of significant covariates with 
the presence of a vertebral fracture as outcome
Variable Odds ratio 95% CI for odds ratio P-value
smoking status 1.77 1.13–2.78 0.01
Bone density 0.99 0.98–0.99 0.001
Abbreviation: CI, confidence interval.
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COPD phenotype that also includes systemic characteris-
tics. This may indicate the necessity to measure CT-derived 
bone density in a specific group of heavy smokers to prevent 
vertebral fractures.
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Table S1 First multiple linear regression model with bone density as outcome
Variable B (SE) P-value
age (years) −1.73 (0.19) 0.001
Pack-years −0.03 (0.06) 0.56
smoking status 8.67 (2.01) 0.001
FeV1 % predicted −0.01 (0.07) 0.88
COPD status 2.02 (2.53) 0.43
Perc15 0.11 (0.06) 0.05
e/I-ratioMlD −0.33 (0.18) 0.07
Abbreviations: B, unstandardized coefficient; COPD, chronic obstructive pulmonary disease; E/I-ratioMlD, expiration to inspiration ratio of mean lung density; FeV1, forced 
expiratory volume in 1 second; Perc15, emphysema score as 15th percentile of attenuation distribution curve on inspiratory scan; se, standard error.
Table S2 logistic regression model of all covariates, with the presence of a fracture as outcome
Variable Odds ratio 95% CI for odds ratio P-value
age (years) 1.00 0.96–1.04 0.95
BMI (kg/m2) 0.94 0.88–1.02 0.12
Pack-years 0.99 0.98–1.01 0.39
smoking status 1.71 1.06–2.78 0.03
Bone density 0.99 0.98–0.99 0.001
FeV1 % predicted 1.01 1.00–1.03 0.13
COPD status 1.11 0.63–1.96 0.72
Perc15 1.00 0.98–1.01 0.47
E/I-ratioMlD 1.01 0.97–1.06 0.52
Pi10 1.55 0.87–2.75 0.14
TI 1.05 0.11–9.82 0.97
Abbreviations: BMI, body mass index; CI, confidence interval; E/I-ratioMlD, expiration to inspiration ratio of mean lung density; FeV1, forced expiratory volume in 1 second; 
Perc15, emphysema score as 15th percentile of attenuation distribution curve on inspiratory scan; Pi10, airway wall thickness at an internal perimeter of 10 mm; TI, tracheal 
index.
Supplementary materials
Bone density is associated with emphysema and air trapping 
in males with and without COPD.
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